Weaver Consulting Group Pfizer Inc Transaction History

Weaver Consulting Group

$287 Million
Q3 2024

A detailed history of Weaver Consulting Group transactions in Pfizer Inc stock. As of the latest transaction made, Weaver Consulting Group holds 13,313 shares of PFE stock, worth $334,555. This represents 0.13% of its overall portfolio holdings.

Number of Shares

13,313

Previous 13,248 0.49%

Holding current value

$334,555

Previous $370,000 4.05%

% of portfolio

0.13%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1,800 - $2,040	65 Added 0.49%	13,313 $385,000
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $5,708 - $6,689	226 Added 1.74%	13,248 $370,000
Q1 2024 Apr 16, 2024	BUY	$25.89 - $29.73 $77,152 - $88,595	2,980 Added 29.68%	13,022 $361,000
Q4 2023 Jan 22, 2024	BUY	$26.13 - $33.94 $262,397 - $340,825	10,042 New	10,042 $289,000
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $15,637 - $20,358	-397 Reduced 7.12%	5,179 $211,000
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $751 - $981	18 Added 0.32%	5,576 $0
Q3 2022 Oct 04, 2022	SELL	$43.76 - $53.42 $3,500 - $4,273	-80 Reduced 1.42%	5,558 $243,000
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $5,350 - $6,344	-115 Reduced 2.0%	5,638 $296,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $18,117 - $22,449	-396 Reduced 6.44%	5,753 $298,000
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $2,066 - $3,062	-50 Reduced 0.81%	6,149 $363,000
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $2,198 - $2,823	56 Added 0.91%	6,199 $267,000
Q2 2021 Jul 06, 2021	SELL	$35.91 - $40.68 $7,936 - $8,990	-221 Reduced 3.47%	6,143 $241,000
Q1 2021 Apr 07, 2021	BUY	$33.49 - $37.77 $19,189 - $21,642	573 Added 9.89%	6,364 $231,000
Q4 2020 Jan 29, 2021	BUY	$33.47 - $42.56 $9,405 - $11,959	281 Added 5.1%	5,791 $213,000
Q2 2020 Jul 24, 2020	BUY	$30.12 - $36.54 $9,066 - $10,998	301 Added 5.78%	5,510 $180,000
Q1 2020 Apr 28, 2020	SELL	$27.03 - $38.62 $42,653 - $60,942	-1,578 Reduced 23.25%	5,209 $170,000
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $73,049 - $82,901	2,219 Added 48.58%	6,787 $244,000
Q3 2019 Nov 22, 2019	BUY	$32.49 - $42.13 $25,992 - $33,704	800 Added 21.23%	4,568 $177,000
Q1 2019 Jun 19, 2019	BUY	$37.5 - $41.2 $141,300 - $155,241	3,768 New	3,768 $162,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Account

Weaver Consulting Group Pfizer Inc Transaction History